Sean M. Emery
Affiliations: | 2014 | Pharmacology | Virginia Commonwealth University, Richmond, VA, United States |
Google:
"Sean Emery"Mean distance: 15.98 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Aron H. Lichtman | grad student | 2014 | VCU | |
| (Combined antiproliferative effects of the aminoalkylindole win55,212-2 and radiation in breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Emery SM, Alotaibi MR, Tao Q, et al. (2014) Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. The Journal of Pharmacology and Experimental Therapeutics. 348: 293-302 |
| Schneider K, Nwizu C, Kaplan R, et al. (2013) The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa. Plos One. 8: e54435 |
| Bristol ML, Emery SM, Maycotte P, et al. (2013) Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? The Journal of Pharmacology and Experimental Therapeutics. 344: 544-52 |
| Emery SM, Sumner ET, Lichtman AH, et al. (2012) Abstract 1453: The cannabinoid Win55, 212-2 enhances the response of breast cancer cells to radiation Cancer Research. 72: 1453-1453 |